A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of Lapatinib
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: lapatinib
Sponsor: GlaxoSmithKline